Viral Vector Market worth $12.8 billion by 2028
According to research report the report Viral Vector Manufacturing Market is projected to reach USD 12.8 billion by 2028 from USD 5.5 billion in 2023, at a CAGR of 18.2% during the forecast period of 2023 to 2028. Download
PDF Brochure: https://www .marketsandmarkets.com/pdfdownloadNew.asp?id=89341986
The Plasmid DNA segment accounted for the largest share, by type in the viral vector & plasmid DNA manufacturing market in 2022.
By type, the viral vector & plasmid DNA manufacturing market has been further categorized as viral vector and plasmid DNA. The plasmid DNA segment held the largest share of the global viral vector and plasmid DNA manufacturing market in 2022.
The downstream manufacturing segment accounted for the largest share of the workflow segment in the viral vector and plasmid DNA manufacturing market in 2022.
The North America region catered the largest share of the viral vector and plasmid DNA manufacturing market in 2022.
Key players in the Viral Vector Manufacturing Market include Lonza Group AG (Switzerland), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), Charles River Laboratories International, Inc. (US), Catalent Inc. (US), WuXi. . AppTec (China)
Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=89341986
- 1
โฆษณา
- ดาวน์โหลดแอปพลิเคชัน
- © 2024 Blockdit
